Efficacy and safety of second-line therapy of docetaxel plus ramucirumab after first-line platinum-based chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer (SCORPION): a multicenter, open-label, single-arm, phase 2 trial
-
Published:2023-12
Issue:
Volume:66
Page:102303
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Matsuzawa Reiko,
Morise MasahiroORCID,
Ito KentaroORCID,
Hataji Osamu,
Takahashi Kosuke,
Koyama Junji,
Kuwatsuka Yachiyo,
Goto YasuhiroORCID,
Imaizumi Kazuyoshi,
Itani Hidetoshi,
Yamaguchi Teppei,
Zenke Yoshitaka,
Oki MasahideORCID,
Ishii MakotoORCID